Eli Lilly and Company (NYSE: LLY) on Tuesday reported higher earnings and revenues for the third quarter of 2022. The company also
Earnings: Highlights of Eli Lilly’s (LLY) Q3 2022 results
Categories
Health Care
Pfizer (PFE) Q3 2022 Earnings: Key financials and quarterly highlights
Pfizer Inc. (NYSE: PFE) reported third quarter 2022 earnings results today. Revenues decreased 6% year-over-year to $22.6 billion. Reported net income increased
Vertex Pharmaceuticals Incorporated (VRTX) Q3 2022 Earnings Call Transcript
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q3 2022 earnings call dated Oct. 27, 2022 Corporate Participants: Susie Lisa -- Senior Vice President, Investor Relations Reshma
BioMarin Pharmaceutical Inc. (BMRN) Q3 2022 Earnings Call Transcript
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) Q3 2022 earnings call dated Oct. 26, 2022 Corporate Participants: Traci McCarty -- Vice President of Investor Relations Jean-Jacques
Merck & Co Inc (MRK) Q3 2022 Earnings Call Transcript
Merck & Co Inc (NYSE:MRK) Q3 2022 Earnings Call dated Oct. 27, 2022. Corporate Participants: Peter Dannenbaum -- Vice President of Investor Relations Robert
ABBV Infographic: AbbVie’s Q3 earnings beat estimates; revenue up 3%
Pharmaceutical company AbbVie, Inc. (NYSE: ABBV) reported a sharp increase in third-quarter adjusted earnings. The bottom line topped expectations, while revenues missed.
Infographic: Highlights of Merck’s (MRK) Q3 2022 earnings
Merck & Co., Inc. (NYSE: MRK) reported a modest increase in adjusted earnings for the third quarter of 2022 when the pharmaceutical
IQVIA Holdings Inc. (IQV) Q3 2022 Earnings Call Transcript
IQVIA Holdings Inc. (NYSE: IQV) Q3 2022 earnings call dated Oct. 26, 2022 Corporate Participants: Nick Childs -- Senior Vice President, Investor Relations and
Thermo Fisher Scientific Inc. (TMO) Q4 2022 Earnings Call Transcript
Thermo Fisher Scientific Inc. (NYSE: TMO) Q4 2022 earnings call dated Oct. 26, 2022 Corporate Participants: Rafael Tejada -- Vice President, Investor Relations Marc
Boston Scientific Corp. (BSX) Q3 2022 Earnings Call Transcript
Boston Scientific Corp. (NYSE: BSX) Q3 2022 earnings call dated Oct. 26, 2022 Corporate Participants: Lauren Tengler -- Vice President, Investor Relations Michael F.
BIIB Stock: Is Biogen an investment worth trying now?
Biogen Inc. (NASDAQ: BIIB) has been going through a rough patch for some time as the company's popular products faced competition and
Bristol Myers Squibb (BMY) Earnings: 3Q22 Key Numbers
Bristol Myers Squibb (NYSE: BMY) reported revenues of $11.2 billion for the third quarter of 2022, down 3% from the same period
Agilysys, Inc (AGYS) Q2 2023 Earnings Call Transcript
Agilysys, Inc (NASDAQ:AGYS) Q2 2023 Earnings Call dated Oct. 25, 2022. Corporate Participants: Jessica Hennessy -- Senior Director of Corporate Strategy and Investor Relations
Centene Corporation (CNC) Q3 2022 Earnings Call Transcript
Centene Corporation (NYSE:CNC) Q3 2022 Earnings Call dated Oct. 25, 2022. Corporate Participants: Jennifer Gilligan -- Senior Vice President of Investor Relations Sarah M.
Novartis AG (NVS) Q3 2022 Earnings Call Transcript
Novartis AG (NYSE: NVS) Q3 2022 earnings call dated Oct. 25, 2022 Corporate Participants: Samir Shah -- Global Head of Investor Relations Vasant Narasimhan -- Chief
Biogen Inc. (BIIB) Q3 2022 Earnings Call Transcript
Biogen Inc. (NASDAQ: BIIB) Q3 2022 earnings call dated Oct. 25, 2022 Corporate Participants: Mike Hencke -- Head, Investor Relations Michel Vounatsos -- Chief Executive Officer
Infographic: Highlights from Biogen’s (BIIB) Q3 2022 earnings results
Pharma giant Biogen Inc. (NASDAQ: BIIB) on Tuesday announced financial results for the third quarter of 2022, reporting a double-digit drop in
Quest Diagnostics Inc. (DGX) Q3 2022 Earnings Call Transcript
Quest Diagnostics Inc. (NYSE: DGX) Q3 2022 earnings call dated Oct. 20, 2022 Corporate Participants: Shawn Bevec -- Vice President Investor Relations Stephen H.
Abbott (ABT) Q3 2022 Earnings Call Transcript
Abbott (NYSE: ABT) Q3 2022 earnings call dated Oct. 19, 2022 Corporate Participants: Scott Leinenweber -- Vice President of Investor Relations, Licensing, and Acquisition
Infographic: Highlights of Intuitive Surgical’s Q3 2022 earnings
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) said its third-quarter adjusted earnings remained unchanged year-over-year, while revenues increased in double digits.
Key highlights from Abbott (ABT) Q3 2022 earnings results
Abbott (NYSE: ABT) reported third quarter 2022 earnings results today. Sales decreased 4.7% year-over-year to $10.4 billion. On an organic basis, sales